Hepatology

Filter

Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives

February 2026

Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.

Can Chitosan Improve Liver Function in NAFLD?

Chitosan, a dietary fibre derived from chitin in fungi, mushrooms, and crustaceans, has shown potential for weight and fat reduction.

Key highlights for primary biliary cholangitis (PBC) from AASLD 2024

Explore the recent advancements and key highlights in primary biliary cholangitis (PBC) presented at the Association for the Study of…

Optimising Liver Surgery with Workflow Management Systems

Methods like preoperative time-outs improve communication but can lead to information overload.

Machine Learning in Liver Fibrosis Diagnosis and Progression

Recent developments in machine learning have allowed researchers to reconstruct long-term disease patterns.

Breakthrough Study Confirms Hepatitis E Vaccine Works in High-Risk Groups

A large-scale study finds that the hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic hepatitis B.

Managing MASLD in Patients with Type 2 Diabetes

The connection between Type 2 diabetes and NAFLD is primarily driven by insulin resistance, which increases free fatty acid levels.

Understanding the burden and measurement of pruritus in PBC

Primary biliary cholangitis (PBC) often causes pruritus, impacting QoL. Validated patient-reported outcomes (PROs), such as PBC-40 an WI-NRS, can assess severity and aid management…

Can Time-Restricted Feeding Improve MAFLD Management?

Time-restricted feeding (TRF), limits food intake to a set daily window, such as the 16:8 model.

Loading posts...

« Previous 1 … 21 22 23 24 25 … 76 Next »